Search - tctmd.com

Displaying 261 - 280 of 432

Sort: Relevancy | Date

Presentation TCT 2016

Overcoming Clinical Design Issues: What to Look for (and Demand) in Ongoing and Future Hypertension Device Trials

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Bryan Williams

October 30, 2016

Presentation TCT 2016

Overcoming RDN Catheter Design Limitations: Issues and Spectrum of Devices

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Horst Sievert

October 30, 2016

Presentation TCT 2016

Renal Denervation for Hypertension: New Insights and A Progress Report From Last Year

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Felix Mahfoud

October 30, 2016

Presentation TCT 2016

Hypertension Treatment Targets Beyond the Kidneys

Presenter: Felix Mahfoud, Michael A. Weber, Atul Pathak

October 30, 2016

Presentation TCT 2016

The Renal Nerves and Their Role in Hypertension: An Updated Synthesis (Anatomy and Pathophysiology)

Presenter: Felix Mahfoud, Michael A. Weber, Michael Joner

October 30, 2016

Presentation TCT 2016

Is There a Role for PCI of Renal Artery Stenosis in Hypertension Management?

Presenter: Felix Mahfoud, Michael A. Weber, Ehtisham Mahmud

October 30, 2016

Presentation TCT 2016

Implications of Recent Hypertension Studies for Optimal BP Targets and Clinical Practice (SPRINT, PATHWAYS, Others)

Presenter: Felix Mahfoud, Michael A. Weber

October 30, 2016

Presentation TCT 2016

Using Virtual Reality in Interventional Cardiology

Presenter: Oscar A. Mendiz, Giora Weisz, Silvio J. Bezerra

October 30, 2016

Presentation TCT 2016

A Percutaneous Shoehorn via Transbrachial Artery Approach in a Staggering Tavi Procedure With Edwards Sapien 3 Aortic Valve in a Patient With Extremely Calcified Aortic Valve

Presenter: Oscar A. Mendiz, Giora Weisz, Caterina Gandolfo

October 30, 2016

Presentation TCT 2016

Peri-Procedural Planning of Renal Sympathetic Denervation using the ReCor Paradise System

Presenter: Oscar A. Mendiz, Giora Weisz, Philipp Lurz

October 30, 2016

Presentation TCT 2016

LV Volume Reduction in Post-AMI, Ischemic Heart Failure Patients

Presenter: Oscar A. Mendiz, Giora Weisz, Horst Sievert

October 30, 2016

Presentation TCT 2015

Featured Vascular Innovation Technologies 5: Denervation in Hypertensive Renal Transplantation Patients Verves Disruptive Nonvascular Catheter Option to Nephrectomy

Presenter: Greg L. Kaluza, Joachim Schofer, Richard R. Heuser

October 15, 2015

Presentation TCT 2015

TCT 90: Sustained Beneficial Effects of Multielectrode Renal Denervation on Cardiac Adaptations in Resistant Hypertension A 24-Month Follow-up Study

Presenter: Michael A. Weber, Stephen G. Worthley, Konstantinos Tsioufis

October 13, 2015

Presentation TCT 2015

TCT 89: Renal Sympathetic Denervation in Treatment-Resistant Essential Hypertension a Sham-Controlled, Double-blinded Randomized Trial (RESET trial)

Presenter: Michael A. Weber, Stephen G. Worthley, Ole Mathiassen

October 13, 2015

Presentation TCT 2015

TCT 88: Transcatheter Perivascular Chemical Neurolysis to Produce Renal Denervation Targeted, Local Delivery of Alcohol as a Viable Alternative to Radiofrequency Approaches

Presenter: Michael A. Weber, Stephen G. Worthley, Tim A. Fischell

October 13, 2015

Presentation TCT 2015

TCT 87: Noninvasive Renal Denervation Study Using Externally Delivered Focused Ultrasound in Severe Resistant Hypertension One-Year Follow-up Results

Presenter: Michael A. Weber, Stephen G. Worthley, Roland E Schmieder

October 13, 2015

Presentation TCT 2015

TCT 86: Safety and Performance of the Next-Generation EnligHTN Renal Denervation System in Patients With Drug-Resistant Hypertension 24-Month Results From a First-in-Human Multicentre Study

Presenter: Michael A. Weber, Stephen G. Worthley

October 13, 2015

Presentation TCT 2015

TCT 85: Safety and Performance of the EnligHTN Renal Denervation System in Patients With Severe Uncontrolled Hypertension Twelve-Month Results From the EnligHTN II Study

Presenter: Michael A. Weber, Stephen G. Worthley, Melvin D. Lobo

October 13, 2015

Presentation TCT 2015

TCT 84: Enhanced Circumferential Ablation Using a Multielectrode Bipolar/Unipolar Over-the-Wire Renal Denervation RF Catheter System With Closed-Loop Sensing

Presenter: Michael A. Weber, Stephen G. Worthley, Elazer R. Edelman

October 13, 2015

Presentation TCT 2015

TCT 83: Long-term (24-Month) Blood Pressure Results of Catheter-Based Renal Artery Denervation SYMPLICITY HTN-3 Randomized Controlled Trial

Presenter: Michael A. Weber, Stephen G. Worthley, Deepak L. Bhatt

October 13, 2015

Advertisement

Overcoming Clinical Design Issues: What to Look for (and Demand) in Ongoing and Future Hypertension Device Trials

Overcoming RDN Catheter Design Limitations: Issues and Spectrum of Devices

Renal Denervation for Hypertension: New Insights and A Progress Report From Last Year

Hypertension Treatment Targets Beyond the Kidneys

The Renal Nerves and Their Role in Hypertension: An Updated Synthesis (Anatomy and Pathophysiology)

Is There a Role for PCI of Renal Artery Stenosis in Hypertension Management?

Implications of Recent Hypertension Studies for Optimal BP Targets and Clinical Practice (SPRINT, PATHWAYS, Others)

Using Virtual Reality in Interventional Cardiology

A Percutaneous Shoehorn via Transbrachial Artery Approach in a Staggering Tavi Procedure With Edwards Sapien 3 Aortic Valve in a Patient With Extremely Calcified Aortic Valve

Peri-Procedural Planning of Renal Sympathetic Denervation using the ReCor Paradise System

LV Volume Reduction in Post-AMI, Ischemic Heart Failure Patients

Featured Vascular Innovation Technologies 5: Denervation in Hypertensive Renal Transplantation Patients Verves Disruptive Nonvascular Catheter Option to Nephrectomy

TCT 90: Sustained Beneficial Effects of Multielectrode Renal Denervation on Cardiac Adaptations in Resistant Hypertension A 24-Month Follow-up Study

TCT 89: Renal Sympathetic Denervation in Treatment-Resistant Essential Hypertension a Sham-Controlled, Double-blinded Randomized Trial (RESET trial)

TCT 88: Transcatheter Perivascular Chemical Neurolysis to Produce Renal Denervation Targeted, Local Delivery of Alcohol as a Viable Alternative to Radiofrequency Approaches

TCT 87: Noninvasive Renal Denervation Study Using Externally Delivered Focused Ultrasound in Severe Resistant Hypertension One-Year Follow-up Results

TCT 86: Safety and Performance of the Next-Generation EnligHTN Renal Denervation System in Patients With Drug-Resistant Hypertension 24-Month Results From a First-in-Human Multicentre Study

TCT 85: Safety and Performance of the EnligHTN Renal Denervation System in Patients With Severe Uncontrolled Hypertension Twelve-Month Results From the EnligHTN II Study

TCT 84: Enhanced Circumferential Ablation Using a Multielectrode Bipolar/Unipolar Over-the-Wire Renal Denervation RF Catheter System With Closed-Loop Sensing

TCT 83: Long-term (24-Month) Blood Pressure Results of Catheter-Based Renal Artery Denervation SYMPLICITY HTN-3 Randomized Controlled Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content